Loading…

Cutaneous involvement in T-lymphoblastic lymphoma

Lymphoblastic lymphoma (LBL) is a rare form of non-Hodgkin's lymphoma (NHL). Cutaneous LBL is seen in less than 20% of patients. Herein, we report the case of a 66-year-old male patient without any previous disease history of note and who was presenting a gradually spreading tumoral lesion of t...

Full description

Saved in:
Bibliographic Details
Published in:Annales de dermatologie et de vénéréologie 2017-04, Vol.144 (4), p.268-274
Main Authors: Nascimbeni, C, Chantepie, S, Brugiere, C, Comoz, F, Salaun, V, Verneuil, L
Format: Article
Language:fre
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 274
container_issue 4
container_start_page 268
container_title Annales de dermatologie et de vénéréologie
container_volume 144
creator Nascimbeni, C
Chantepie, S
Brugiere, C
Comoz, F
Salaun, V
Verneuil, L
description Lymphoblastic lymphoma (LBL) is a rare form of non-Hodgkin's lymphoma (NHL). Cutaneous LBL is seen in less than 20% of patients. Herein, we report the case of a 66-year-old male patient without any previous disease history of note and who was presenting a gradually spreading tumoral lesion of the scalp, several purplish macules and nodules on the trunk, and a single spinal adenopathy. A thoracic-abdominal-pelvic CT scan performed for acute renal failure, revealed extensive infiltration of retroperitoneal tissue. Skin biopsies and staging tests indicated LBL-T with associated cutaneous, bone and lymph node retroperitoneal lesions with no mediastinal mass. After two months of treatment with CHOP (four courses), the cutaneous lesions and abdominal tumoral mass had regressed and renal function had returned to normal. There have been 13 reported cases of LBL with cutaneous involvement; most of these patients were young (under 30 years) and presented multiple cutaneous lesions (nodules or tumors) associated with numerous peripheral adenopathies, invasion of the bone marrow, and in many cases, a mediastinal mass. The clinical presentation of LBL-T in our case is novel on account of the cutaneous sites, associated with abdominal tumoral syndrome, without mediastinal infiltration, and with a single peripheral adenopathy, in an elderly subject.
doi_str_mv 10.1016/j.annder.2017.01.001
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1872877928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1872877928</sourcerecordid><originalsourceid>FETCH-LOGICAL-p562-657456bf990df971b9339775b20a553b155a6fb0bd6cba15ba52f3ee313e8ac43</originalsourceid><addsrcrecordid>eNo1T81OhDAY7EHjrugbGMPRC9iv5Wvp0RBdTTbxwp20UCKbFpDCJvv2krCe5ieTyQwhT0BToCBeT6nu-8ZOKaMgUwoppXBD9hQQEiV4viP3IZxWk-Uc78iO5SxjVLE9gWKZdW-HJcRdfx7c2XrbzyuPy8Rd_PgzGKfD3NXxprx-ILetdsE-XjEi5cd7WXwmx-_DV_F2TEYULBEoMxSmVYo2rZJgFOdKSjSMakRuAFGL1lDTiNpoQKORtdxaDtzmus54RF622nEafhcb5sp3obbObWsryCXLpVTro4g8X6OL8bapxqnzerpU_y_5H1ODU4k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1872877928</pqid></control><display><type>article</type><title>Cutaneous involvement in T-lymphoblastic lymphoma</title><source>ScienceDirect Journals</source><creator>Nascimbeni, C ; Chantepie, S ; Brugiere, C ; Comoz, F ; Salaun, V ; Verneuil, L</creator><creatorcontrib>Nascimbeni, C ; Chantepie, S ; Brugiere, C ; Comoz, F ; Salaun, V ; Verneuil, L</creatorcontrib><description>Lymphoblastic lymphoma (LBL) is a rare form of non-Hodgkin's lymphoma (NHL). Cutaneous LBL is seen in less than 20% of patients. Herein, we report the case of a 66-year-old male patient without any previous disease history of note and who was presenting a gradually spreading tumoral lesion of the scalp, several purplish macules and nodules on the trunk, and a single spinal adenopathy. A thoracic-abdominal-pelvic CT scan performed for acute renal failure, revealed extensive infiltration of retroperitoneal tissue. Skin biopsies and staging tests indicated LBL-T with associated cutaneous, bone and lymph node retroperitoneal lesions with no mediastinal mass. After two months of treatment with CHOP (four courses), the cutaneous lesions and abdominal tumoral mass had regressed and renal function had returned to normal. There have been 13 reported cases of LBL with cutaneous involvement; most of these patients were young (under 30 years) and presented multiple cutaneous lesions (nodules or tumors) associated with numerous peripheral adenopathies, invasion of the bone marrow, and in many cases, a mediastinal mass. The clinical presentation of LBL-T in our case is novel on account of the cutaneous sites, associated with abdominal tumoral syndrome, without mediastinal infiltration, and with a single peripheral adenopathy, in an elderly subject.</description><identifier>ISSN: 0151-9638</identifier><identifier>DOI: 10.1016/j.annder.2017.01.001</identifier><identifier>PMID: 28242092</identifier><language>fre</language><publisher>France</publisher><subject><![CDATA[Acute Kidney Injury - etiology ; Aged ; Antineoplastic Combined Chemotherapy Protocols - administration & dosage ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bone and Bones - pathology ; Cyclophosphamide - administration & dosage ; Doxorubicin - administration & dosage ; Humans ; Immunophenotyping ; Leukemic Infiltration - pathology ; Lymph Nodes - pathology ; Male ; Mercaptopurine - administration & dosage ; Methotrexate - administration & dosage ; Organ Specificity ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology ; Prednisone - administration & dosage ; Retroperitoneal Space ; Skin - pathology ; Vincristine - administration & dosage]]></subject><ispartof>Annales de dermatologie et de vénéréologie, 2017-04, Vol.144 (4), p.268-274</ispartof><rights>Copyright © 2017 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28242092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nascimbeni, C</creatorcontrib><creatorcontrib>Chantepie, S</creatorcontrib><creatorcontrib>Brugiere, C</creatorcontrib><creatorcontrib>Comoz, F</creatorcontrib><creatorcontrib>Salaun, V</creatorcontrib><creatorcontrib>Verneuil, L</creatorcontrib><title>Cutaneous involvement in T-lymphoblastic lymphoma</title><title>Annales de dermatologie et de vénéréologie</title><addtitle>Ann Dermatol Venereol</addtitle><description>Lymphoblastic lymphoma (LBL) is a rare form of non-Hodgkin's lymphoma (NHL). Cutaneous LBL is seen in less than 20% of patients. Herein, we report the case of a 66-year-old male patient without any previous disease history of note and who was presenting a gradually spreading tumoral lesion of the scalp, several purplish macules and nodules on the trunk, and a single spinal adenopathy. A thoracic-abdominal-pelvic CT scan performed for acute renal failure, revealed extensive infiltration of retroperitoneal tissue. Skin biopsies and staging tests indicated LBL-T with associated cutaneous, bone and lymph node retroperitoneal lesions with no mediastinal mass. After two months of treatment with CHOP (four courses), the cutaneous lesions and abdominal tumoral mass had regressed and renal function had returned to normal. There have been 13 reported cases of LBL with cutaneous involvement; most of these patients were young (under 30 years) and presented multiple cutaneous lesions (nodules or tumors) associated with numerous peripheral adenopathies, invasion of the bone marrow, and in many cases, a mediastinal mass. The clinical presentation of LBL-T in our case is novel on account of the cutaneous sites, associated with abdominal tumoral syndrome, without mediastinal infiltration, and with a single peripheral adenopathy, in an elderly subject.</description><subject>Acute Kidney Injury - etiology</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bone and Bones - pathology</subject><subject>Cyclophosphamide - administration &amp; dosage</subject><subject>Doxorubicin - administration &amp; dosage</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Leukemic Infiltration - pathology</subject><subject>Lymph Nodes - pathology</subject><subject>Male</subject><subject>Mercaptopurine - administration &amp; dosage</subject><subject>Methotrexate - administration &amp; dosage</subject><subject>Organ Specificity</subject><subject>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis</subject><subject>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology</subject><subject>Prednisone - administration &amp; dosage</subject><subject>Retroperitoneal Space</subject><subject>Skin - pathology</subject><subject>Vincristine - administration &amp; dosage</subject><issn>0151-9638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNo1T81OhDAY7EHjrugbGMPRC9iv5Wvp0RBdTTbxwp20UCKbFpDCJvv2krCe5ieTyQwhT0BToCBeT6nu-8ZOKaMgUwoppXBD9hQQEiV4viP3IZxWk-Uc78iO5SxjVLE9gWKZdW-HJcRdfx7c2XrbzyuPy8Rd_PgzGKfD3NXxprx-ILetdsE-XjEi5cd7WXwmx-_DV_F2TEYULBEoMxSmVYo2rZJgFOdKSjSMakRuAFGL1lDTiNpoQKORtdxaDtzmus54RF622nEafhcb5sp3obbObWsryCXLpVTro4g8X6OL8bapxqnzerpU_y_5H1ODU4k</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>Nascimbeni, C</creator><creator>Chantepie, S</creator><creator>Brugiere, C</creator><creator>Comoz, F</creator><creator>Salaun, V</creator><creator>Verneuil, L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201704</creationdate><title>Cutaneous involvement in T-lymphoblastic lymphoma</title><author>Nascimbeni, C ; Chantepie, S ; Brugiere, C ; Comoz, F ; Salaun, V ; Verneuil, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p562-657456bf990df971b9339775b20a553b155a6fb0bd6cba15ba52f3ee313e8ac43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2017</creationdate><topic>Acute Kidney Injury - etiology</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bone and Bones - pathology</topic><topic>Cyclophosphamide - administration &amp; dosage</topic><topic>Doxorubicin - administration &amp; dosage</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Leukemic Infiltration - pathology</topic><topic>Lymph Nodes - pathology</topic><topic>Male</topic><topic>Mercaptopurine - administration &amp; dosage</topic><topic>Methotrexate - administration &amp; dosage</topic><topic>Organ Specificity</topic><topic>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis</topic><topic>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology</topic><topic>Prednisone - administration &amp; dosage</topic><topic>Retroperitoneal Space</topic><topic>Skin - pathology</topic><topic>Vincristine - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nascimbeni, C</creatorcontrib><creatorcontrib>Chantepie, S</creatorcontrib><creatorcontrib>Brugiere, C</creatorcontrib><creatorcontrib>Comoz, F</creatorcontrib><creatorcontrib>Salaun, V</creatorcontrib><creatorcontrib>Verneuil, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annales de dermatologie et de vénéréologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nascimbeni, C</au><au>Chantepie, S</au><au>Brugiere, C</au><au>Comoz, F</au><au>Salaun, V</au><au>Verneuil, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutaneous involvement in T-lymphoblastic lymphoma</atitle><jtitle>Annales de dermatologie et de vénéréologie</jtitle><addtitle>Ann Dermatol Venereol</addtitle><date>2017-04</date><risdate>2017</risdate><volume>144</volume><issue>4</issue><spage>268</spage><epage>274</epage><pages>268-274</pages><issn>0151-9638</issn><abstract>Lymphoblastic lymphoma (LBL) is a rare form of non-Hodgkin's lymphoma (NHL). Cutaneous LBL is seen in less than 20% of patients. Herein, we report the case of a 66-year-old male patient without any previous disease history of note and who was presenting a gradually spreading tumoral lesion of the scalp, several purplish macules and nodules on the trunk, and a single spinal adenopathy. A thoracic-abdominal-pelvic CT scan performed for acute renal failure, revealed extensive infiltration of retroperitoneal tissue. Skin biopsies and staging tests indicated LBL-T with associated cutaneous, bone and lymph node retroperitoneal lesions with no mediastinal mass. After two months of treatment with CHOP (four courses), the cutaneous lesions and abdominal tumoral mass had regressed and renal function had returned to normal. There have been 13 reported cases of LBL with cutaneous involvement; most of these patients were young (under 30 years) and presented multiple cutaneous lesions (nodules or tumors) associated with numerous peripheral adenopathies, invasion of the bone marrow, and in many cases, a mediastinal mass. The clinical presentation of LBL-T in our case is novel on account of the cutaneous sites, associated with abdominal tumoral syndrome, without mediastinal infiltration, and with a single peripheral adenopathy, in an elderly subject.</abstract><cop>France</cop><pmid>28242092</pmid><doi>10.1016/j.annder.2017.01.001</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0151-9638
ispartof Annales de dermatologie et de vénéréologie, 2017-04, Vol.144 (4), p.268-274
issn 0151-9638
language fre
recordid cdi_proquest_miscellaneous_1872877928
source ScienceDirect Journals
subjects Acute Kidney Injury - etiology
Aged
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Bone and Bones - pathology
Cyclophosphamide - administration & dosage
Doxorubicin - administration & dosage
Humans
Immunophenotyping
Leukemic Infiltration - pathology
Lymph Nodes - pathology
Male
Mercaptopurine - administration & dosage
Methotrexate - administration & dosage
Organ Specificity
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology
Prednisone - administration & dosage
Retroperitoneal Space
Skin - pathology
Vincristine - administration & dosage
title Cutaneous involvement in T-lymphoblastic lymphoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A14%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutaneous%20involvement%20in%20T-lymphoblastic%20lymphoma&rft.jtitle=Annales%20de%20dermatologie%20et%20de%20v%C3%A9n%C3%A9r%C3%A9ologie&rft.au=Nascimbeni,%20C&rft.date=2017-04&rft.volume=144&rft.issue=4&rft.spage=268&rft.epage=274&rft.pages=268-274&rft.issn=0151-9638&rft_id=info:doi/10.1016/j.annder.2017.01.001&rft_dat=%3Cproquest_pubme%3E1872877928%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p562-657456bf990df971b9339775b20a553b155a6fb0bd6cba15ba52f3ee313e8ac43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1872877928&rft_id=info:pmid/28242092&rfr_iscdi=true